(Total Views: 490)
Posted On: 04/29/2025 9:33:23 PM
Post# of 154593
July 2024 settlement. Today Cytodyn used that same time reference again.
"The Company has also now confirmed survival outcomes in a group of patients with mTNBC and four prior lines of treatment who are alive more than 48 months after receiving leronlimab."
Around July 2025 is 60 months.
Dr. Pestell 2nd conference is ??
July 2025.
ESMO they will say the "more than 48 months" are being monitored & from all signs, continuing to be on the reported trajectory. Or, somethin like that.
But the information gaps disappear between May - July, if needed.
( expecting a partner & FDA / EU info )
"The Company has also now confirmed survival outcomes in a group of patients with mTNBC and four prior lines of treatment who are alive more than 48 months after receiving leronlimab."
Around July 2025 is 60 months.
Dr. Pestell 2nd conference is ??
July 2025.
ESMO they will say the "more than 48 months" are being monitored & from all signs, continuing to be on the reported trajectory. Or, somethin like that.
But the information gaps disappear between May - July, if needed.
( expecting a partner & FDA / EU info )
(2)
(0)
